Literature DB >> 10232299

Psychiatric patients and treatments in 1997: findings from the American Psychiatric Practice Research Network.

H A Pincus1, D A Zarin, T L Tanielian, J L Johnson, J C West, A R Pettit, S C Marcus, R C Kessler, J S McIntyre.   

Abstract

Despite extensive studies on the epidemiology of mental disorders and advances in the treatment of these conditions, there is a paucity of detailed information concerning the characteristics of psychiatric patients and how treatments are administered in routine psychiatric practice. This 1997 observational study collected detailed information from 417 psychiatrists on the demographic, diagnostic, clinical, and treatment characteristics of a systematic sample of 1228 patients. Six hundred thirty-seven patients (51.9%) were women and the mean patient age was 41.9 years. The most common diagnostic category (53.7%) was mood disorders, followed by schizophrenia/psychotic disorders (14.6%), anxiety disorders (9.3%), and disorders of childhood (7.7%). Six hundred seventy-one patients (54.6%) had at least one comorbid Axis I condition and almost half (49.8%) had a history of psychiatric hospitalization. Patients received a mean of 2.0 psychotherapeutic medications, most commonly antidepressants (62.3%). Findings demonstrate that psychiatrists in routine practice treat a patient population with severe, complex conditions.

Entities:  

Mesh:

Year:  1999        PMID: 10232299     DOI: 10.1001/archpsyc.56.5.441

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  16 in total

1.  Demographic and practice characteristics of psychiatrists who primarily treat patients with substance use disorders.

Authors:  Ivan D Montoya; Diane M Herbeck; Dace S Svikis; Diana J Fitek; Steven C Marcus; Harold A Pincus
Journal:  Am J Addict       Date:  2003 May-Jun

2.  Mental health service use 1-year after the World Trade Center disaster: implications for mental health care.

Authors:  Joseph A Boscarino; Richard E Adams; Charles R Figley
Journal:  Gen Hosp Psychiatry       Date:  2004 Sep-Oct       Impact factor: 3.238

3.  Challenges to evidence-based medicine: a comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network.

Authors:  Deborah A Zarin; Julia L Young; Joyce C West
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-01       Impact factor: 4.328

4.  Determinants of health plan membership among patients in routine U.S. psychiatric practice.

Authors:  Michael T Compton; Paul S Weiss; V L Phillips; Joyce C West; Nadine J Kaslow
Journal:  Community Ment Health J       Date:  2006-04

5.  Electronic medical record availability and primary care depression treatment.

Authors:  Jeffrey S Harman; Kathryn M Rost; Christopher A Harle; Robert L Cook
Journal:  J Gen Intern Med       Date:  2012-02-04       Impact factor: 5.128

6.  Treatment compliance in patients with comorbid psychiatric and substance use disorders.

Authors:  Diane M Herbeck; Diana J Fitek; Dace S Svikis; Ivan D Montoya; Steven C Marcus; Joyce C West
Journal:  Am J Addict       Date:  2005 May-Jun

7.  Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice.

Authors:  Ivan D Montoya; Diane M Herbeck; Dace S Svikis; Harold Alan Pincus
Journal:  Am J Addict       Date:  2005 Oct-Dec

Review 8.  How an age of anxiety became an age of depression.

Authors:  Allan V Horwitz
Journal:  Milbank Q       Date:  2010-03       Impact factor: 4.911

9.  The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.

Authors:  Michael T Compton; Paul S Weiss; Joyce C West; Nadine J Kaslow
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-10-25       Impact factor: 4.328

10.  Patterns of medical resource and psychotropic medicine use among adult depressed managed behavioral health patients.

Authors:  Francisca Azocar; Loren M McCarter; Brian J Cuffel; Thomas W Croghan
Journal:  J Behav Health Serv Res       Date:  2004 Jan-Mar       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.